Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection

NCT02553083 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT02553083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02553083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
Lead sponsor
Rabin Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
October 22, 2015
Completion date
December 31, 2021
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infection due to helicobacter pylori (h. pylori)